![]() |
![]() |
![]() |
|
![]() |
| Wednesday, June 3 |
8 a.m.-Noon
9 a.m.-10:30 a.m.
9 a.m.-Noon
9 a.m.-11 a.m.
Session 22. Healing From Grief: Child and Parent Losses
41. A Mother's Grief
42. Grown-Up Tears
9 a.m.-Noon
9 a.m.-12:30 p.m.
9 a.m.-4 p.m.
10 a.m.-3 p.m.
11 a.m.-2 p.m.
Session 24. DSM-IV New Diagnostic Issues
45. Psychotic Disorders
46. Anxiety Disorders
47. Mood Disorders
11 a.m.-12:30 p.m.
Session 21. Psychopharmacology
62. Olanzapine: Safe in Clozapine-Induced Agranulocytosis L. Kola Oyewumi, M.D.
.
63. Sildenafil for Erectile Dysfunction: A One-Year Study Waguih R. Guirguis, M.D.
.
64. Adverse Event Profiles Associated With Long-Term Fluoxetine Treatment Roy Tamura, Ph.D.
.
Session 22. Mental Health Stresses in Children
65. Psychological Functioning and Child Abuse in Adolescents Charles Sanislow, Ph.D
..
66. Clinical Judgment in Reports of Childhood Sexual Abuse Cheryl Gore-Felton, Ph.D.
.
67. Homeless Children: Stressors and Mental Health Problems Bonnie T. Zima, M.D.
.
Session 23. Brain Imaging
68. Basal Ganglia Choline Levels in True Drug Response Maurizio Fava, M.D
..
69. Neuroanatomy of Attention to Emotional Experience Richard D. Lane, M.D.
.
70. Atrophy and Metabolite Abnormality in Movement Disorder Subhendra Sarkar, Ph.D.
.
Session 24. Bipolar Group: At-Risk Population
71. Which Unipolar Depressives Are Really Bipolar? Joseph F. Goldberg, M.D.
.
72. Postpartum Course of Bipolar Illness Ruta M. Nonacs, M.D.
.
73. Treatment of Bipolar Spectrum Symptoms Ronald A. Rabin, M.D.
.
Session 25. Treatment Issues in Anxiety Disorders
74. Cognitive and/or Behavioral Therapy in Social Phobia Jean A. Cottraux, M.D.
.
75. The Association Between Symptom Changes and Clinical Outcome in Panic Disorder David Michelson, M.D.
.
76. Platelet and Plasmatic MAO in Anxiety Disorders Oscar R. Carrion, M.D.
.
Session 26. Diagnosis and Methodology in Personality Disorders
77. Divalproex for Aggression in Personality Disorders Richard J. Kavoussi, M.D.
.
78. Internal Consistency and Overlap of DSM-IV Personality Disorders Carlos M. Grilo, Ph.D.
.
79. Identifying Personality Disorders: Toward the Development of a Clinical Screening Instrument H. George Nurnberg, M.D
..
Session 27. Forensic Psychiatry
80. Psychiatric Disability Exam for Employment Discrimination and the Americans With Disabilities Act Lauren J. Wylonis, M.D.
.
81. The Effect of Depression on Competency: A Survey Kevin C. Hails, M.D.
.
82. Malpractice Law and Managed Care: New Developments Eugene L. Lowenkopf, M.D.
.
Session 28. Psychiatric Epidemiology
83. Prevalence of Dementia in Centenarians Ben A. Blansjaar, M.D.
.
84. Is Schizophrenia on the Decline? Carolyn M. Woogh, M.D.
.
85. A Prospective Analysis of Alcohol Use Disorders Rosa Maria Crum, M.D.
.
Session 29. The Wide World of Neuropsychiatry
86. Drug-Induced Delirium in Intensive Care Units Kwo-Hwa Tseng, M.D.
.
87. Role of Sympathoadrenal Dysfunction in Hyperthermia Ronald J. Gurrera, M.D.
.
88. Epilepsy and Psychosis: A Neurodevelopmental Hypothesis Anthony Feinstein, M.D.
.
Noon-1:30 p.m.
Noon-2 p.m.
12:30 p.m.-2 p.m.
1 p.m.-4 p.m.
1 p.m.-5 p.m.
2 p.m.-3:30 p.m.
2 p.m.-5 p.m.
Session 28. Childhood Issues
53. Healing Wounded Hearts
54. When the Bough Breaks
55. Breaking the Cycle
2 p.m.-5:30 p.m.
S60. Clinical Subtyping of Schizophrenia
S61. Anxiety Spectrum Disorders: A New Millennium
S62. Juvenile Offenders: Modern Issues for Child Psychiatry
S63. Detection and Treatment of Stimulant Abuse
S64. The Relationship Between Seasonality, Eating, and Mood
S65. Personality Disorders Research in Canada
S66. Dynamic Perspectives on Treatment Resistance
S67. Pathways to Homelessness
S68. Psychosocial Aspects of HIV Risk Among Young IV Drug Users
S69. The Many Faces of the Drug Problem
S70. Doctors and Drug Companies: Unholy Alliance or Match Made in Heaven?
S71. Medication: Changing a Person or Treating a Patient?
S72. Herbal Medicine: Ancient Roots to Modern Use
S73. Classic and Atypical Neuroleptics in Dementia
S74. Catatonia and Other Motor Syndromes: How Closely Related?
S75. Practice Profile of United States and Canadian Psychiatrists Joint Session With the Canadian Psychiatric Association
A. Practice Profile Survey by the Canadian Psychiatric Association: Study, Design, and Results D. Blake Woodside, M.D.
S76. Psychiatric Aspects of Epilepsy
S77. New Anticonvulsants in Mood Disorders: An Update
S78. Collaborative Study of Personality Disorders
S79. Current Trends in Russian Psychiatry
S80. Medications Development for Substance Dependence Collaborative Session With the National Institute on Drug Abuse
S81. Hormones and Depression: Treatment Implications
S82. Psychiatric Ethics: Facing the 21st Century
S83. Estrogen, Progesterone, Testosterone, and Dysphoria
S84. Cutting-Edge Polypharmacy for Mood Disorders
S85. Oklahoma City: Trauma and Renewal After Terrorism
S86. Societal and Cultural Adaptations to Trauma
IS44. Management of Mental Disorders in Baby Boomers and Beyond Supported by Pfizer U.S. Pharmaceutical
IS45. Predicting Outcomes of Antidepressant Treatment Supported by Pharmacia & Upjohn Company Inc.
IS46. Therapeutic Challenges in Geriatric Psychiatry Supported by Forest Laboratories Inc.
IS47. Practical Alzheimer's Disease Management: A Comparative Review of New Compounds, Diagnosis, Treatment, and Outcomes Assessment Supported by Eisai Inc. and Pfizer Inc.
Session 31. Psychiatric Perspectives on Race and Boxing Joint Session With the International Society for Sport Medicine
S88. Finding the Person in Writing About Patients
S89. French and American: Vive La Difference!
S90. Music Therapy in Psychiatric Care
S91. Computer-Assisted Psychotherapy
S92. Current Perspectives on Psychiatry and Religion
S93. Psychotherapies in Community Psychiatry Joint Session With the American Association of Community Psychiatrists
S94. Genetics of Personality and Behavior2 p.m.-5 p.m.
Symposia
S59. Outcome Measurement in Psychiatry: A Critical Review
A. Outcome Measurement: Definition, History, and Review of Available Tools Waguih W. Ishak, M.D.
.
B. The Ideal Outcome Measurement Tool Susan Eisen, Ph.D.
.
C. Critical Appraisal of Different Outcome Measurement Tools Jean Endicott, Ph.D.
.
D. Implementing Outcome Assessment in a Clinical Facility Lloyd I. Sederer, M.D.
.
E. Outcome Measures: Computers, Managed Care, and Rehabilitation Zebulon C. Taintor, M.D.
.
A. Associated Syndromes in Chronic Schizophrenia Paul C. Bermanzohn, M.D.
.
B. Is There Room for a Schizo-Obsessive Subtype? Joseph Zohar, M.D.
.
C. How Vulnerable Are Schizophrenia Patients to Depression? Martin Harrow, Ph.D.
.
D. Antidepressants and Benzodiazepines in Schizophrenia Samuel G. Siris, M.D.
.
E. Is Panic a Schizophrenia Subtype? Paul C. Bermanzohn, M.D.
.
A. The Anxiety Spectrum and the Obsessive-Compulsive Spectrum Eric Hollander, M.D.
.
B. New Findings in the Neurobiology and Treatment of Panic Jack M. Gorman, M.D.
.
C. Social Phobia: Part of a Shyness Spectrum? Murray B. Stein, M.D.
.
D. PTSD Joseph Zohar, M.D
..
E. Diagnosing and Treating Coexisting Anxiety and Depression Norman Sussman, M.D.
.
A. A Systems Approach to Mental Health in Juvenile Facilities William M. Womack, M.D.
.
B. Teaching Clinical Skills to Correction Staff: A Necessity, Not an Option Lisa M. Boesky, Ph.D.
.
C. Suicidal and Self-Mutilating Behavior in Incarcerated Adolescents Jana Ewing, Ph.D.
.
D. Treatment of Traumatic Bereavement With Incarcerated Youth Edward K. Rynearson, M.D.
.
Collaborative Session With the National Institute on Drug Abuse
A. Detection of Stimulant Abuse Jeffery N. Wilkins, M.D
..
B. Psychosocial Treatment for Stimulant Abusers Douglas M. Ziedonis, M.D.
.
C. Pharmacological Treatment of Stimulant Abuse David A. Gorelick, M.D.
.
D. Psychiatric Comorbidity in Stimulant Abusers Richard N. Rosenthal, M.D.
.
E. Methamphetamine Abuse: New Developments Steven L. Batki, M.D.
.
A. Serotonin Dysfunction in Bulimia and SAD Robert D. Levitan, M.D.
.
B. Seasonality of Mood and Eating in Bulimia and SAD Allan S. Kaplan, M.D.
.
C. Comorbidity of SAD and Bulimia in a Clinic and Community Sample Anthony J. Levitt, M.D.
.
D. Bulimia Nervosa and SAD: Overlapping Treatment Raymond W. Lam, M.D.
.
A. The Etiology of Personality Disorder Traits John Livesley, M.D.
.
B. Prospective Follow-Up of Borderline Personality: Mechanisms of Change Paul S. Links, M.D.
.
C. Implications of Research on Psychological Risk Factors in BPD Joel F. Paris, M.D.
.
D. Risk Factors for Borderline Pathology in Children Jaswant Guzder, M.D.
.
E. Defenses in Personality and Depressive Disorders J. Christopher Perry, M.D.
.
A. Treatment Resistance and the Dynamics of the Dual Treatment Relationship James M. Ellison, M.D.
.
B. Readiness for Change in Treatment Resistance Barri A. Belnap, M.D.
.
C. Enactment and Treatment-Refractory Depression Eric M. Plakun, M.D.
.
D. Treatment Resistance: A Cognitive-Behavioral Perspective Michael E. Thase, M.D
..
A. An Integrative Approach to Research With Homeless Persons George S. Tolomiczenko, Ph.D.
.
B. Prevalence of Mental Illness Among Homeless Persons Donald A. Wasylenki, M.D.
.
C. Pathways Into First-Time Homelessness Paula N. Goering, Ph.D.
.
D. Neuropsychological and Personality Factors George S. Tolomiczenko, Ph.D.
.
E. HIV Prevalence and Risk Factors in an Adult Homeless Population Mark H. Halman, M.D.
.
A. Overview of the Collaborative Injection-Drug Users Study (CIDUS II) Edgar Monterroso, M.D.
.
B. Psychopathology and HIV Risk Behavior Among Young Injection-Drug Users Patricia Simon-Morse, Ph.D
..
C. Injection-Drug Users and HIV Risk in Chicago Demographics and Gang Behavior Lorna Thorpe, M.P.H.
.
D. Violence, Trauma, and HIV Among Young Injection-Drug Users Nance Sohler, Ph.D.
.
Joint Session With the InterAmerican Council of Psychiatric Organizations
A. Substance Abuse: A Vision From the United States Pedro Ruiz, M.D
..
B. Substance Abuse: A South-American Perspective Carlos Leon-Andrade, M.D.
.
C. The International Drug Trafficking Roberto E. Chaskel, M.D.
.
D. Substance Abuse and HIV/AIDS: A Problem for the Americas Rodolfo D. Fahrer, M.D.
.
E. Substance Abuse: A Caribbean Perspective Sharon C. Harvey, M.D.
.
A. Promotion in the Guise of Education Irwin N. Hassenfeld, M.D.
.
B. The Developmental History of a Pharmaceutical Lecture Joseph Di Giacomo, M.D.
.
C. Psychology and Ethics of Giving and Receiving Carl Mindell, M.D.
.
D. Organizational Perspective on Industry Support Carolyn B. Robinowitz, M.D.
.
A. Stability of Personality Disorders With Treatment for Chronic Depression Robert M.A. Hirschfeld, M.D.
.
B. Does Medication Change Personality Organization? Carlos Blanco, M.D.
.
C. Defense Mechanisms and Axis I: Searching for Stability Linda S. Mullen, M.D.
.
D. Biological Studies in Personality Disorders Emil F. Coccaro, M.D.
.
A. Herbal Medicine and Psychiatry: Potential for Toxicity Michael W. Smith, M.D.
.
B. Kava: Ancient Beverage to Modern Psychotherapeutic Medicine Dennis J. McKenna, Ph.D.
.
C. Antidepressant Activity of Hypericum Perforatum: St. John's Wort Jerry M. Cott, Ph.D.
.
D. Plant Entheogens as Medicine Charles S. Grob, M.D.
.
A. A Neurochemical Rationale for the Use of Neuroleptics in Dementia Dario F. Mirski, M.D.
.
B. Classic Neuroleptics in Dementia Davangere P. Devanand, M.D.
.
C. Atypical Neuroleptics in Dementia S. Craig Risch, M.D.
.
D. Efficacy and Safety of Atypical Neuroleptics in Dementia Jacobo E. Mintzer, M.D.
.
A. Diagnostic and Therapeutic Relevance of Catatonia Brendan T. Carroll, M.D.
.
B. Catatonia and Noncatatonic Motor Syndromes in Schizophrenia Peter Braunig, M.D.
.
C. Similarity of Catatonia and NMS Andrew J. Francis Jr., M.D.
.
D. Prevalence and Clinical Significance of Catatonic Symptoms in Mania Stephanie Kruger, M.D.
.
E. Neurological Soft Signs in Schizophrenia Subtypes Oliver Rommel, M.D.
.
.
B. Findings From the American Psychiatric Association's Practice Research Network Study of Psychiatric Patients and Treatments Harold Alan Pincus, M.D.
.
C. The Practice Profile Study by the Canadian Psychiatric Association: Methodological Issues Elizabeth Lin, Ph.D.
.
D. The American Psychiatric Association's Practice Research Network Study of Psychiatric Patients and Treatments: Methodological Issues Deborah A. Zarin, M.D.
.
E. Canadian Human Resource Surveys: Policy Implications Nady El-Guebaly, M.D.
.
F. The American Psychiatric Association's Practice Research Network Study of Patients and Treatments: Policy Implications John S. McIntyre, M.D.
.
A. Diagnosis and Outcome of Psychogenic Nonepileptic Events Andres Kanner, M.D.
.
B. Brain SPECT in Paroxysmal Psychiatric Episodes Thomas H. Jobe, M.D.
.
C. Treatment of Psychogenic Nonepileptic Events Prema V. Sanne, M.D.
.
D. Lamotrigine in the Treatment of Epileptic Psychosis Ovidio A. De Leon, M.D.
.
A. Pharmacology and Pharmacokinetics of New Anticonvulsants Terence A. Ketter, M.D.
.
B. Lamotrigine in Bipolar Disorder Joseph R. Calabrese, M.D.
.
C. An Open Trial of Gabapentin in Bipolar Disorder L. Trevor Young, M.D.
.
D. Gabapentin and Lamotrigine Monotherapy in Mood Disorder: An Update Mark A. Frye, M.D.
.
E. Neuroimaging of Response to Lamotrigine and Gabapentin Timothy A. Kimbrell, M.D.
.
A. An Overview of the Study and the Sample John G. Gunderson, M.D
..
B. Diagnostic Interview for DSM-IV Personality Disorders: Test-Retest and Interrater Reliability Mary C. Zanarini, Ed.D.
.
C. Functional Impairment in Four Personality Disorder Types Andrew E. Skodol II, M.D.
.
D. Axis II Comorbidity of DSM-IV Personality Disorders Carlos M. Grilo, Ph.D.
.
E. Stability of Personality Disorder: Diagnoses and Criteria M. Tracie Shea, Ph.D
.
F. Dimensions and Categories in Personality Disorder Leslie C. Morey, Ph.D.
.
A. Development of Russian Psychiatry: Current Condition and Trends Valery N. Krasnov, M.D.
.
B. Economic Research Program in Russian Psychiatry Vassiey Yastrebov, M.D.
.
C. Psychiatric Care in Russia: Situation and Perspectives Isaac Ya. Gurovich, Ph.D.
.
D. Russian Psychiatry and the Law: Facts and Problems Svetlana Polubinskya
.
E. Alcohol and Substance Abuse Disorders in Russia for the Last Two Decades (1976-1996) Alexander V. Nemtsov, Ph.D
..
F. Biological Treatment of Mental Disorders in Russia Sergey N. Mosolov, M.D.
.
G. Criteria of Depression in General Somatic Practice Olga P. Vertogradova, Ph.D.
.
A. Targeted Subgroups for Cocaine Pharmacotherapies Thomas R. Kosten, M.D.
.
B. Targets for Medication to Prevent Relapse Charles P. O'Brien, M.D.
.
C. Levomethadyl Acetate Hydrochloride and Buprenorphine Treatment Eric C. Strain, M.D.
.
D. Cocaine Pharmacotherapy: Human Laboratory Studies Marian W. Fischman, Ph.D.
.
E. Pharmacotherapy for Opiate and Stimulant Dependence Frank J. Vocci, Ph.D.
.
A. Testosterone and Male Depression: A Clinical Review Stuart N. Seidman, M.D.
.
B. Exogenous DHEA and Antiglucocorticoids in Depression Victor I. Reus, M.D.
.
C. Estrogen and Depressive Disorders in Women Mary F. Morrison, M.D.
.
D. Thyroid Hormones and Mood Disorders Gregory M. Sullivan, M.D.
.
A. Misuse and Abuse of Psychiatry: A 50-Year Overview Paul Chodoff, M.D.
.
B. Professional Boundaries in Psychiatry Glen O. Gabbard, M.D.
.
C. The Ethics of Managed Mental Health Care Stephen A. Green, M.D.
.
D. The Ethics of For-Profit Managed Care Is an Oxymoron Leon Eisenberg, M.D.
.
E. Codes of Ethics and Psychiatry Sydney Bloch, M.D.
.
A. Estrogen and Testosterone: Natural Antidepressants? Susan Rako, M.D.
.
B. Menopause, Mood, MAO, and Hormone Replacement Edward L. Klaiber, M.D.
.
C. Sex Therapy in Women With Testosterone Deficiency Barbara D. Bartlik, M.D.
.
A. Switching Strategies in Refractory Depression Maurizio Fava, M.D.
.
B. Lithium Augmentation of the Newer Antidepressants Andrew A. Nierenberg, M.D.
.
C. The Use of Pindolol to Potentiate Antidepressant Medication Pierre Blier, M.D.
.
D. Rational Polypharmacy for Refractory Bipolar Disorder Andrew L. Stoll, M.D.
.
E. Inositol: A Novel Augmentation for Mood Disorders Robert H. Belmaker, M.D.
.
A. Terrorism and Community Resilience Robert Vincent, Ph.D
..
B. Terrorism Impacts Oklahoma City Students Sandra Allen, Ph.D
..
C. Traumatic Bereavement in Mothers and Grandmothers Suzanne W. Whittlesey, R.N.
.
D. Trauma and Recovery in Highly Exposed Adults Phebe M. Tucker, M.D.
.
E. Resiliency in Oklahoma City Fire Fighters Sara Jo Nixon, Ph.D.
.
A. Does Vengeance Heal Psychic Trauma? James Gilligan, M.D
..
B. Individual and Communal Recovery in Bosnia-Herzegovina Judith L. Herman, M.D.
.
C. Violence Turns Me On: Nazi Skinhead Adolescents in Germany Annette Streeck-Fischer
.
D. Human Rights Abuses in Turkey: Examples and Challenges Sahika Yuksel, M.D.
.
E. After Apartheid: South Africa's Truth and Reconciliation Merle Friedman
3 p.m.-5 p.m.
New Research Poster Session
4 p.m.-5 p.m.
Media Session
Session 29. Computer Production Workshop
7 p.m.-10 p.m.
Industry-Supported Symposia
IS43. Neurocognition in Schizophrenia Supported by Janssen Pharmaceutica and Research Foundation
.
A. Neurocognitive Deficits in Schizophrenia: Traits or States? Keith Nuechterlein, Ph.D.
.
B. Neurocognitive Considerations for Functional Outcome Michael F. Green, Ph.D.
.
C. Spatial Working Memory in Schizophrenia Susan R. McGurk, Ph.D.
.
D. Cognitive Changes With Aging in Schizophrenia Philip D. Harvey, Ph.D.
.
E. Cognitive Deficits in First-Episode Schizophrenia Lili C. Kopala, M.D.
.
F. Impact of Antipsychotic Pharmacotherapy on Neurocognition William C. Wirshing, M.D
..
.s
A. Aging and Adaptation to Life and Illness: A Psychiatric Perspective George E. Vaillant, M.D.
.
B. Late-Life Depression Donald P. Hay, M.D.
.
C. Anxiety, Agitation, and Insomnia Carl Salzman, M.D.
.
D. Interface of Depression and Medical Illness Richard C. Veith, M.D.
.
E. Behavioral Symptoms of Alzheimer's and Other Dementias Sanford I. Finkel, M.D.
.
.
A. Clinical Predictors of Response to Antidepressants Andrew A. Nierenberg, M.D.
.
B. Neurophysiologic Predictors of Treatment Response Ian A. Cook, M.D.
.
C. Neurotransmitter Depletion and Outcome in Depression Pedro L. Delgado, M.D.
.
D. Neuroimaging Indicators of Treatment Effectiveness Harold A. Sackeim, Ph.D.
.
E. Differential Therapeutic Responses in Depression Andrew F. Leuchter, M.D.
.
.
A. Diagnosis and Biology of Late-Life Depression and Dementia P. Murali Doraiswamy, M.D.
.
B. The Management of Anxiety in Late Life Alastair J. Flint, M.B.
.
C. Treatment-Resistant Depression in Late Life Benoit H. Mulsant, M.D.
.
D. Comorbid Dementia and Depression in Late Life Barnett S. Meyers, M.D.
.
E. Behavioral Disturbances of Dementia Bruce G. Pollock, M.D.
.
.
A. Recognition of Alzheimer's Disease: The Importance of Early Diagnosis to Desirable Patient Outcomes Rachelle Doody, M.D.
.
B. Pathogenesis of Alzheimer's Disease Jeffrey L. Cummings, M.D.
.
C. Cognitive Enhancement in Alzheimer's Disease: A Comparative Review of New and Emerging Therapies Trey Sunderland, M.D.
.
D. Treating Behavioral Manifestations in Patients With Alzheimer's Disease: Differential Diagnosis and Therapies David L. Sultzer, M.D.
.
E. Assessing Alzheimer's Disease Treatment Response: Outcome Strategies for the Office Practice Ira R. Katz, M.D.
.
F. Why Treat? The Economic Impact of Early Diagnosis and Effective Treatment of Alzheimer's Disease Peter J. Neumann, Sc.D.
.
Media Sessions
Session 30. Japanese and Vietnamese Stories of Trauma and Recovery
56. Momiji: Japanese Maple
57. Kim's Story: The Road From Vietnam
58. The Shot Heard Round the World
59. When We Were Kings: The Untold Story of the Rumble in the Jungle
Symposia
S87. The Role of Coercion in Psychiatry
A. Coercion of Motivation: General Issues Naomi B. Heller, M.D.
.
B. The History of Involuntary Treatment John P. Shemo, M.D.
.
C. History of Involuntary Treatment of Those With Addiction William W. Van Stone, M.D.
.
D. Role of Coercion in Hospital Management Lynn DeLacy, M.S.
.
E. Role of Coercion in Treatment of the Homeless Mentally Ill Lien A. Hung, M.D.
.
A. Katherine Holden: A Patient Jeanne L. Steiner, D.O.
.
B. The Reunion Jaak Rakfeldt, Ph.D
..
C. On Rounds in a Psychiatric Hospital Dolly D. Jacobson, M.S.W.
.
D. Jorge's Story Carole T. Goldberg, Ph.D.
.
E. The Portrait Charles D. Atkins, M.D.
.
A. Is There a Cultural Psychiatry in France? Jean-Charles Pascal, M.D.
.
B. Is There a Cultural Psychiatry in America? Rodrigo A. Mu-oz, M.D.
.
C. The Treatment of Substance Abuse in France Simon-Daniel Kipman, M.D.
.
D. The Treatment of Substance Abuse in America Robert B. Millman, M.D.
.
E. A Day in the Life of a French Psychiatrist With a Liberal Practice Jean-Michel Thurin, M.D.
.
F. A Day in the Life of a Psychiatrist in America Robert Michels, M.D.
.
A. Music Therapy and Psychiatry: An Overview John S. McIntyre, M.D.
.
B. Music Therapy for an Aging Population David S. Smith, Ph.D.
.
C. Music Therapy for Short-Term Inpatient Psychiatric Treatment Carol L. Shultis, M.Ed.
.
D. Music-Assisted Cognitive-Behavioral Interventions Thomas H. Kerr, M.A.
.
E. Reimbursement for Music Therapy Services Bryan C. Hunter, Ph.D.
.
A. Computer-Assisted Treatment of Dual-Diagnosis Patients Robert J. Bischoff, Ph.D.
.
B. Therapy Partner: A Computer-Assisted Psychotherapy Program Robert A. Bailey, M.D.
.
C. Computer-Assisted Psychotherapy for Brief Treatment Groups Jerrold L. Shapiro, Ph.D.
.
A. A Cross-Cultural Perspective of Psychiatry and Religion Ronald M. Wintrob, M.D.
.
B. Cults and New Religious Movements Marc Galanter, M.D.
.
C. Religion and Psychiatry: Bioethics as Arbiter of Mutual Respect Laurence J. O'Connell, Ph.D., STD
.
D. Psychiatry and Religion: Changes in Research and Training David B. Larson, M.D.
.
A. Psychotherapies in Community Psychiatry Clifton R. Tennison Jr., M.D.
.
B. Psychotherapies and Psychosis Joel S. Feiner, M.D.
.
C. Psychotherapy for People of Color With Serious Mental Illness Andres J. Pumariega, M.D.
.
D. Family Psychoeducation: Outcome and Application William R. McFarlane, M.D.
.
E. Biopsychosocial Treatments for Depressed Patients Gabor I. Keitner, M.D.
.
A. Genetics of Personality and Behavior Kathleen R. Merikangas, Ph.D
..
B. The Genetic Structure of Personality Disorder Traits John Livesley, M.D.
.
C. Gene Mapping of Human Personality Traits C. Robert Cloninger, M.D.
.
D. Genetics of Antisocial Personality Disorder Remi J. Cadoret, M.D.
.
E. Genetics of Schizotypal and BPD Larry J. Siever, M.D.
.